Feasibility of clinical trial recruitment for cerebral amyloid angiopathy: A specialist single centre experience

摘要

Introduction: Cerebral amyloid angiopathy (CAA) is a small vessel disease characterised by vascular amyloid-beta deposition and recurrent intracerebral haemorrhage, for which there are limited data on the practicalities of clinical trial recruitment.